Institutional investors hold a majority ownership of GILD through the 94.62% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Biotechnology industry. Last, during the quarter ended December 2013, these large investors purchased a net $11.4 million shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
BROWN ADVISORY LLC Bought 6.2 Million shares of Gilead Sciences Inc
TEMASEK HOLDINGS PTE LTD. (INVES... Bought 5.6 Million shares of Gilead Sciences Inc
LORD, ABBETT & CO. LLC Bought 3.5 Million shares of Gilead Sciences Inc